AzTrials
AzTrials

Spastic Diplegia Cerebral Palsyspastic CPNCT07878949

Comparative Effects of Under Water Exercise and Radial Extracorporeal Shockwave Therapy on Lower-Limb Spasticity, Gross Motor Function, and Quality of Life in Children With Spastic Diplegic Cerebral Palsy: A Randomized Controlled Trial

A study testing Group A and Group B in people with Spastic Diplegia Cerebral Palsy, run by Emad Eldin Mohamed at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Children with spastic diplegic cerebral palsy often present with lower-limb spasticity, limited gross motor function, and reduced quality of life. Effective interventions are needed to improve functional outcomes and daily participation. Read more about this study

Who is it for?
Ages 9 to 12 years
Conditions the study is for
Spastic Diplegia Cerebral Palsy
What is being tested?
Group A and Group B
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
10 Feb 2024to 8 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children had a MAS score of 1 to 4 in the affected lower limbs, were classified as GMFCS levels I to III, had the ability to follow verbal instructions and participate in the treatment, had no acute illness at the time of recruitment, with no changes in medications affecting muscle tone during the study period program were eligible for the study. Inclusion criteria for mothers were as follows: (1) housewives or those who gave up work due to their child's condition, (2) 20 years or older, and (3) primary caregivers.

Who cannot join

  • Children with non-spastic CP, orthopedic surgery for the lower extremities within the previous 12 months, botulinum toxin injections within the previous 6 months, fixed contractures or severe deformities, uncontrolled epilepsy

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Bassam Ahmed Nabil

    October 6 City, Cairo Governorate, 78345

Other trials in Egypt

About this study

Children with spastic diplegic cerebral palsy often present with lower-limb spasticity, limited gross motor function, and reduced quality of life. Effective interventions are needed to improve functional outcomes and daily participation.

Read the detailed description

Spastic diplegia is one of the most prevalent bilateral forms of CP; it mostly affects the lower limbs and is often associated with gait disturbances, restricted movement, and impaired functional independence. Damage to the motor cortex and corticospinal pathways leads to imbalance between excitatory and inhibitory neural mechanisms, resulting in increased reflex excitability and abnormal patterns of muscle activation. Therefore, children with spastic diplegia often experience progressive restrictions in motor performance and participation as they grow.

Motor dysfunction in children with spastic diplegia develops from impaired motor control, involuntary muscle activation and muscle weakness leading to several clinical manifestations such as delayed gross motor development, persistence of basic reflexes such as the asymmetric tonic neck reflex, and increased resistance to passive movement. During the early stages of development, spontaneous movements may be limited or atypical, while locomotor development is often characterized by delayed independent walking with reduced gait efficiency. These impairments contribute significantly to limitations in functional mobility, self-care activities, and social participation.

Beyond physical impairments, children with spastic diplegia may experience reduced independence and emotional difficulties, all of which contribute to diminished health-related quality of life. Previous studies have established that improve functional ability can enhance the participation in family and community activities lead to improvement in QoL outcomes. Therefore, contemporary rehabilitation approaches emphasize the promotion of activity, participation, and psychosocial well-being. Improving QoL has become a central goal of intervention, reflecting a shift toward patient-centered care that prioritizes significant engagement and overall life satisfaction alongside functional recovery.

Being tested
Group A, Group B
Keywords
cerebral palsy, Spastic Diplegia Cerebral Palsy, underwater exercise, radial extracorporeal shock wave therapy
Medical subject headings
Cerebral palsy, spastic, diplegic, Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group AOther

    Underwater exercise was conducted five times per week for 12 weeks. Each session took place for 60 minutes in a therapy pool with water temperatures between 33-35°С. The water depth ranged from chest deep to waist deep, depending on the functional level and progress of each participant. Sessions were structured into five parts. Each session began with 10 minutes of warm-up consisting of water walking with support, slow water marching, and body awareness exercises using aquatic foam noodles. After the warm-up, patients spent 15 minutes practicing neuromotor control in buoyancy. The goals of this portion were to reduce co-contraction of muscles and increase ability to have selective motor control.

  • Group BOther

    Group B received a Targeted Neuromodulatory Shockwave Protocol (TNMSP). The protocol involves the combined application of extracorporeal shockwave therapy (ESWT) and the targeted immediate functional activation. The rationale behind the treatment is the concept that spasticity reduction achieved through the use of ESWT would facilitate enhanced motor learning and promote the emergence of normal motor patterns.

    The intervention was lasted for 12 weeks and involved 1 ESWT and 2 functional activation sessions weekly. The ESWT component of the protocol was selected to maximize the neuromodulatory potential by promoting plasticity within the central nervous system and to consolidate the motor patterns introduced during the functional activation

Study groups in NCT07878949
Study groupRoleWhat they receive
group A: underwater exerciseExperimentalAquatic Neuromotor Repatterning Program (ANRP)
Receives: Other: Group A
group B: radial extracorporeal shock wave therapy.ExperimentalTargeted Neuromodulatory Shockwave Protocol (TNMSP)
Receives: Other: Group B

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1- Modified Ashworth Scale (MAS)

    The MAS measures the muscle group's resistance to passive stretching on a six-point ordinal scale that ranges from 0 (no increase in muscle tone) to 4. A score of 1 indicates a slight increase in muscle tone with a catch and release, whereas a score of 2 indicates a more notable increase in muscle tone across the range of motion. A score of 3 shows a significant increase in muscle tone; passive movement is complex, and there is a "catch" at a particular place in the range of motion. A score of 4 represents stiff flexion or extension.

    Measured: 12 weeks

Secondary outcomes (2)
  1. 2- The Gross Motor Function Measure-66 (GMFM-66)

    The Gross Motor Function Measure (GMFM) is a standardized tool for evaluating gross motor functions in children and adolescents with motor impairments, particularly CP. It is frequently used in rehabilitative settings to monitor development. The GMFM-66 is a subset of the GMFM-88's original 88 items organized into five dimensions: lying and rolling (4 items), sitting (15 items), crawling and kneeling (10 items), standing (13 items), and walking, running, and jumping (24 items).

    Measured: 12 weeks

  2. 3- Pediatric Quality of Life Inventory (PedsQL)

    PedsQL TM is developed to measure children's health-related quality of life in the form of physical, psychological, and social functioning of the child and allows for the measurement of both overall (generic) and disease-specific quality of life. The four scales that comprise this generic battery are Physical Functioning (8 items), Emotional Functioning (5 items), Social Functioning (5 items), and School Functioning (5 items). Evidence of discriminatory and construct validity supports its use as a reliable and valid measure of health-related quality of life among children's populations.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2026
  2. Study start10 Feb 2024
  3. Primary completion22 Aug 2025
  4. Study completion8 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07878949
Sponsor's protocol ID
987897
Acronym
spastic CP
Status last verified
Oct 2026
First submitted
11 Oct 2026
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Group A and Group B in people with Spastic Diplegia Cerebral Palsy, run by Emad Eldin Mohamed at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1- Modified Ashworth Scale (MAS) (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in